Skip to main content
. 2016 Mar 22;14(2):313–320. doi: 10.5114/aoms.2016.58667

Table III.

CXCL9 concentrations and CXCL9 index (ICXCL9) in the CSF and serum of TBE patients as compared to the control group (C)

Parameter I N = 24 II N = 24 C N = 13 P-value
CSF CXCL9 [pg/ml] 215 (100–346) 166 (119–240) 6 (5–23) I vs. II, NS
I vs. C, p < 0.001
II vs. C, p < 0.001
Serum CXCL9 [pg/ml] 111 (91–137) 138 (113–163) 58 (51–62) I vs. II, NS
I vs. C, p < 0.001
II vs. C, p < 0.001
ICXCL9 2.0 (0.9–3.4) 1.2 (0.9–1.6) 0.2 (0.1–0.3) I vs. II, p < 0.001
I vs. C, p < 0.001
II vs. C, p < 0.001

ICXCL9 was determined as follows: CSF CXCL9 concentration divided by serum CXCL9 concentration. Results are presented as medians and interquartile ranges. C – control group, CSF – cerebrospinal fluid, CXCL9 – monokine-induced by γ-interferon, ICXCL9 – CXCL9 index, TBE – tick-borne encephalitis.